"A phase I study of carboxyamidotriazole orotate (CTO) in of advanced solid tumors." by Alan Sandler

Selected Works of Walter J. Urba, MD, PhD

Follow Contact

Article

A phase I study of carboxyamidotriazole orotate (CTO) in of advanced solid tumors.

Journal of Clinical Oncology (2017)

Alan Sandler, Genentech
Matthew Hiram Taylor, Oregon Health & Science University
Walter John Urba
Antonio Marcilio Padula Omuro, Memorial Sloan Kettering Cancer Center
Barry Douglas Anderson, National Institutes of Health
Daniel Hansen
Brenda Fisher, Providence Portland Medical Center
Alisa J Claeys
Amy Greathouse
Sean McLean, Princeton University
Rashida A. Karmali, Duke University

Link

Disciplines

Medicine and Health Sciences and
Pathology

Publication Date

January 30, 2017

Citation Information

Alan Sandler, Matthew Hiram Taylor, Walter John Urba, Antonio Marcilio Padula Omuro, et al.. "A phase I study of carboxyamidotriazole orotate (CTO) in of advanced solid tumors." Journal of Clinical Oncology (2017)
Available at: http://works.bepress.com/walter-urba/104/